AHL
PACB icon

Abel Hall LLC’s Pacific Biosciences PACB Stock Holding History

Abel Hall LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Sell
14,963
-7,736
-34% -$11.2K ﹤0.01% 936
2026
Q1 		$30K Buy
22,699
+6,208
+38% +$11.1K 0.01% 775
2025
Q4 		$30.8K Buy
16,491
+5,403
+49% +$10.4K 0.01% 683
2025
Q3 		$14.2K Sell
11,088
-895
-7% -$1.21K 0.01% 319
2025
Q2 		$14.9K Buy
+11,983
New +$13.8K 0.01% 273

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
KCPG
Kavar Capital Partners Group Leawood, Kansas $812M AUM 29.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Abel Hall LLC's PACB Position: Q2 2026 in Review

Abel Hall LLC reduced its Pacific Biosciences (PACB) stake by 34% in Q2 2026, selling an estimated $11.2K and leaving 14,963 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Abel Hall LLC first reported a position in PACB in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.8K in Q4 2025. 39 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Abel Hall LLC held 14,963 shares of Pacific Biosciences worth $25.1K as of Q2 2026.
  • Abel Hall LLC sold 7,736 Pacific Biosciences shares in Q2 2026, an estimated $11.2K.
  • Pacific Biosciences made up ﹤0.01% of Abel Hall LLC's portfolio in Q2 2026, its #936 holding.
  • Abel Hall LLC first reported a position in Pacific Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Abel Hall LLC's Pacific Biosciences position peaked at $30.8K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.